Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5306106
Max Phase: Preclinical
Molecular Formula: C16H24N2O3S
Molecular Weight: 324.45
Associated Items:
ID: ALA5306106
Max Phase: Preclinical
Molecular Formula: C16H24N2O3S
Molecular Weight: 324.45
Associated Items:
Canonical SMILES: CCC(NS(=O)(=O)c1ccc(C)cc1)C(=O)N1CCCCC1
Standard InChI: InChI=1S/C16H24N2O3S/c1-3-15(16(19)18-11-5-4-6-12-18)17-22(20,21)14-9-7-13(2)8-10-14/h7-10,15,17H,3-6,11-12H2,1-2H3
Standard InChI Key: KCUNCRQFGIOATB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 324.45 | Molecular Weight (Monoisotopic): 324.1508 | AlogP: 2.06 | #Rotatable Bonds: 5 |
Polar Surface Area: 66.48 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.37 | CX Basic pKa: | CX LogP: 2.38 | CX LogD: 2.38 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.90 | Np Likeness Score: -1.47 |
1. Izquierdo, M; Lin, D; De Rycker, M. (2023) RapidFire TcLAP Compounds Screening, [10.6019/CHEMBL5305021] |
Source(1):